Anthropic IPO by the Numbers: The $61 Billion Share Sale, $900 Billion Compute Bet and Valuation Test
Anthropic's IPO prospectus reveals a $70–$78 price range, a $61bn public share sale at the midpoint, $33.2bn in nine-month sales, almost $901bn in compute commitments, and a difficult valuation equation.
Wealth / The Compound journalPhoto: Claude brand logo by Anthropic; self-hosted original-shape artwork via Lobe Icons, also documented on Wikimedia Commons (PD-textlogo; trademarked) · Illustrative image.
Compound’s IPO analysis, 16 November 2026. The headline number is not Anthropic’s net loss. It is how much future revenue and profit are already implied by the price investors are being asked to pay.
Anthropic, the maker of Claude, has entered the public-market roadshow with an indicative price range of $70–$78 per share and 825 million Class A shares for sale. At the $74 midpoint, that is a $61.05 billion public offering before fees. But that figure is not its equity valuation, not the amount all shareholders receive and not even the entire funding package.
The 10 November 2026 SEC prospectus is unusually revealing. It gives the share split, quarterly revenue and operating costs, the balance sheet, cash flows, prospective dilution and contracts for almost $901 billion of future infrastructure spending. The 13 November Reuters roadshow report adds an important distinction: prospective investors are valuing the business on forecasts several years ahead, not just the earnings visible today.
This is a deeper numerical assessment of the proposed Anthropic IPO (anticipated Nasdaq ticker ANT). It is separate from our earlier analysis of Anthropic’s $80.7 billion first-half accounting loss, which explains why that number alone is not a cash-burn estimate.
The Anthropic IPO at a glance
| Metric | Latest disclosed figure | What it means |
|---|---|---|
| Proposed public offer | 825 million Class A shares | Includes newly issued and existing shares |
| Indicative price | $70–$78 | Not a final IPO or market price |
| Public offering at $74 | $61.05bn gross | 825m × $74 |
| New shares sold by Anthropic | 801.35m | Gross proceeds go to the company |
| Existing shares sold | 23.65m | Gross proceeds go to selling owners, not Anthropic |
| Parallel strategic investment | $26.0bn | Separate private Class N placement, conditional on closing |
| Estimated company proceeds | $84.6bn net | IPO primary sale plus placement, at $74, after estimated fees and expenses |
| Q3 2026 reported revenue | $16.956bn | Three months ended 30 September |
| First nine months 2026 revenue | $33.242bn | Recognised revenue, not an annualised run rate |
| October annualised run rate | ~$81bn | Company metric; not GAAP revenue or a guaranteed forecast |
| Nine-month GAAP operating result | -$1.260bn | Much smaller loss than the headline net loss |
| Nine-month GAAP net result | -$104.039bn | Includes $94.324bn from financing-liability fair-value changes |
| Compute and infrastructure commitments | ~$900.9bn | Multi-year purchase and lease obligations, not cash spent today |
| Cash plus short-term investments, 30 September | $131.845bn | Before proposed IPO/placement proceeds |
Source: Anthropic’s amended SEC registration statement, filed 10 November. Dollar values are US dollars; amounts are rounded and may be unaudited where labelled in the filing. Transaction amounts are proposed, not completed.
1. What does the $61 billion IPO actually raise?
The proposed deal has three different money flows. Treating them as interchangeable makes the IPO look more straightforward than it is.
| Flow, at $74 indicative midpoint | Shares | Gross cash | Recipient |
|---|---|---|---|
| Newly issued Class A shares | 801.35m | $59.30bn | Anthropic |
| Existing owners’ secondary shares | 23.65m | $1.75bn | Selling shareholders |
| Total public offering | 825.00m | $61.05bn | Both groups |
| Separate Class N private placement | ~351.35m | $26.00bn | Anthropic |
| Public offering and placement combined | — | $87.05bn | Includes $1.75bn paid to existing owners |
The separate $26 billion placement is allocated to an investor group including Google, Nvidia, AMD, Microsoft, Broadcom, Micron and TSMC-linked interests, with conditions described in the prospectus. It is not an additional $26 billion of public Class A IPO subscriptions.
Anthropic estimates $84.6 billion in net proceeds to itself at the $74 midpoint, from the primary public shares and the private placement, after offering discounts and expenses. That is different from the $61.05 billion gross public deal. The company also specifies approximately $3.8 billion of anticipated tax withholding and remittance connected to settling certain employee restricted share units. It plans to apply remaining funds broadly to working capital, hiring, infrastructure and other corporate uses; it has not promised that every dollar is available as unrestricted cash for GPUs.
There is also an underwriter option to buy up to 123.75 million additional new shares. At the midpoint those would represent about $9.16 billion gross if exercised; they are not part of the 825 million base offer. The prospectus estimates company net proceeds from the IPO plus placement could rise to $93.7 billion if the option is fully used.
The investor takeaway: one headline about the IPO’s size conceals the actual primary financing, cash taken out by sellers and the separate strategic investment. Those distinctions matter when judging the resulting balance sheet and who is funding whom. Source: SEC prospectus, “The Offering” and “Use of Proceeds”.
2. Revenue went from $2 billion a quarter to almost $17 billion. Can that continue?
The strongest part of Anthropic’s investment case is the acceleration in realised revenue. These are the quarterly numbers in the SEC filing, not projections:
| Quarter | Recognised revenue | Sequential change |
|---|---|---|
| Q4 2025 | $2.040bn | — |
| Q1 2026 | $4.731bn | +132% |
| Q2 2026 | $11.555bn | +144% |
| Q3 2026 | $16.956bn | +47% |
From Q3 2025’s $1.382 billion, Q3 2026 revenue grew approximately 12.3 times. That is exceptional at this scale. It is also why an investor cannot simply extrapolate Q2’s 144% quarterly growth indefinitely: the growth rate already slowed to 47% in Q3, even as sales rose by another $5.4 billion.
The prospectus records $33.242 billion of recognised revenue in the first nine months of 2026, versus $2.545 billion in the same period of 2025. Adding Q4 2025 to the three 2026 quarters gives approximately $35.3 billion of trailing-12-month recognised revenue through September 2026.
Contrast that with the company’s approximately $81 billion October 2026 Run-Rate Revenue. The latter annualises a recent month or 28-day period; it is not the same as revenue booked over 12 months, a backlog, or a firm projection. That short-period measurement is more than twice the historical trailing-12-month total because the business has expanded so rapidly. It could overstate durable activity if usage changes, customers churn or pricing falls. Anthropic itself cautions about these limitations in the SEC risk factors.
An important distinction for valuation: paying for a business on $81 billion of annualised activity is materially different from paying for $35 billion already recognised in the last year. Neither denominator tells an investor what future cash margins will be. Source: SEC prospectus, quarterly results and Run-Rate Revenue definition.
3. Why $104 billion of net losses does not mean $104 billion of cash burned
The prospectus reports a $104.039 billion net loss for the first nine months of 2026. Almost $94.324 billion of that total arose from changes in the measured value of convertible notes, derivatives and related financing instruments as Anthropic’s estimated value rose. That is an accounting charge, largely rather than a cheque written for $94 billion that quarter.
But dismissing the entire loss would be equally misleading. On a GAAP operating basis, Anthropic lost $1.260 billion over those nine months. A business that grows quickly can still have meaningful model-training, delivery, personnel and sales costs. Financing conversions can also change dilution and economic ownership; non-cash does not mean no consequences.
| Accounting and cash-flow measure | Nine months to September 2026 |
|---|---|
| Revenue | $33.242bn |
| Operating expenses | $34.502bn |
| GAAP operating loss | -$1.260bn |
| Financing-liability fair-value change | -$94.324bn |
| GAAP net loss | -$104.039bn |
| Net cash from operating activities | +$6.569bn |
Positive operating cash flow in this period is encouraging but is not proof that Anthropic can fund all future data-centre construction and equipment commitments from its customers’ payments. Cash flow depends on timing of collections and vendor payments, and investing cash outflows contain purchases of securities as well as infrastructure-related expenditure. It would be incorrect to label the entire $36.5 billion nine-month investing outflow as capital expenditure.
The company’s September cash and short-term-investment holdings were approximately $131.8 billion, plus separately restricted cash. That is a large liquidity cushion, but it must be assessed against the timetable of commitments, additional financing needs, contractual restrictions and uncertain revenue. Source: SEC prospectus, financial statements and liquidity discussion.
4. Compute is the biggest swing factor in the IPO economics
Revenue can scale dramatically in AI, but the cost of serving and training models does not disappear. Anthropic reported $9.863 billion of compute and infrastructure costs in Q3 2026, compared with $5.558 billion in Q2.
| Quarter | Revenue | Compute/infrastructure cost | Cost as share of revenue |
|---|---|---|---|
| Q1 2026 | $4.731bn | $3.387bn | 72% |
| Q2 2026 | $11.555bn | $5.558bn | 48% |
| Q3 2026 | $16.956bn | $9.863bn | 58% |
Computing cost as a share of sales improved sharply in Q2, then worsened in Q3. The filing describes $5 billion of short-term compute commitments that cost significantly more than comparable capacity contracted over longer periods. Despite higher revenue, Q3 moved back to a $567 million GAAP operating loss, from a $974 million operating profit in Q2. A company whose adjusted profits look attractive still needs to demonstrate durable GAAP margins and free cash flow across several quarters.
Now consider the balance of contracted spending. Anthropic discloses about $900.9 billion of purchase and lease commitments, largely for computing and infrastructure, entered into as of and after 30 September 2026. Of that total:
- Approximately $70.7 billion is due within 12 months of 30 September 2026.
- Approximately $451.6 billion is expected before the end of 2030.
- Substantially all of the remainder extends across 2031–2045.
These are not $900.9 billion of bank debt, nor a single immediate invoice. They include different contracts, maturities and provisions, some involving partner financing or capacity that has not yet begun service. Yet they are a material economic exposure. If capacity becomes available before sufficient customer demand, costs can land before sales. If AI model pricing declines faster than computing efficiency improves, the margin improvement investors expect may not arrive.
A simple sensitivity illustrates the stakes. At Q3 2026’s $16.956 billion revenue, each additional five percentage points of compute cost as a share of revenue reduces quarterly operating contribution by roughly $848 million, all else equal. That is a scenario calculation, not a forecast. At much higher revenue, each percentage point of infrastructure efficiency could be worth billions annually. Source: SEC prospectus, operating results and contractual commitments.
5. Is Anthropic worth $1 trillion or $1.4 trillion? Share count explains the difference
The price range is straightforward; the equity value is not.
At $74 per share, the prospectus’s illustrative post-offering Class A and Class N ownership table shows approximately 13.087 billion economically outstanding shares. Multiplying them produces an approximate $968 billion basic share-value calculation. At the top of the proposed $78 range, a corresponding basic count gives an equity value of roughly $1.02 trillion (subject to price-dependent Class N issuance). This is not the amount raised in the IPO.
Some news reports cite an implied value around $1.3 trillion–$1.4 trillion on a fully diluted basis. That broader convention accounts for the potential effect of options, unsettled awards and equity-plan reserves. The totals can differ because some shares are merely reserved for future issuance rather than already outstanding. Investors should inspect the actual option strike prices, treasury-stock treatment, restricted-share settlements and resulting fully diluted count before quoting a single valuation as definitive.
One particularly useful line in the filing is the illustrative $8.21 pro forma adjusted net tangible book value per share against a $74 offer price. Anthropic calculates $65.79 of immediate book-value dilution per newly purchased share at the midpoint. That does not predict a 89% fall in the share price: accounting book value is not the same as a growth company’s market value. It does underline that investors are paying overwhelmingly for earnings potential, software economics, technological leadership and future strategic opportunity rather than tangible net assets.
The latest May Series H financing placed Anthropic at a $965 billion post-money value. A comparison with prospective IPO equity values needs a consistent share-count basis and adjustment for fresh cash, partner financing and outstanding convertibles. Sources: SEC prospectus, “Capitalization”, “Dilution”, and “Principal and Selling Stockholders”; Reuters roadshow report.
6. What revenue and multiples are embedded in the IPO discussion?
Reuters reported on 13 November that some underwriting-bank estimates point to approximately $52–53 billion of 2026 revenue, $135–137 billion in 2027, and $270–280 billion in 2028. These are reported external banking projections, not audited historical results, binding corporate guidance or guaranteed future sales.
To make that uncertainty explicit, use $52.5 billion for 2026 and $275 billion for 2028 as illustrative midpoints, then compare those with two valuation bases.
| Illustrative valuation | Versus $52.5bn 2026 projected sales | Versus $275bn 2028 projected sales |
|---|---|---|
| $968bn basic equity value, $74/share example | 18.4× | 3.5× |
| $1.33tn illustrative diluted equity value | 25.3× | 4.8× |
These are equity-value-to-revenue ratios, not conventional enterprise-value-to-sales multiples. Enterprise value requires careful treatment of cash, convertible financing and other claims, and the fully diluted comparison depends on how potential shares are counted. The table is a transparent scale comparison, not an investment bank valuation.
Notice how attractive a future-revenue multiple can look if the business reaches the optimistic forecast. Getting there from approximately $52.5 billion in 2026 to $275 billion in 2028 would require more than five times the sales in two years. Model performance, enterprise adoption, competitor pricing, margins and infrastructure availability all have to cooperate.
To show how sensitive valuation is to these assumptions, take three hypothetical 2028 revenue scenarios and a fixed 5× equity-to-revenue illustration:
| Hypothetical 2028 revenue | At 5× sales | Interpretation |
|---|---|---|
| $200bn | $1.0tn | Growth below reported bank midpoint |
| $275bn | $1.375tn | Around reported bank midpoint |
| $350bn | $1.75tn | Growth above reported bank midpoint |
This is not a price target or fair-value estimate. It shows that a $75 billion difference in annual revenue at a 5× multiple can shift a theoretical equity valuation by $375 billion. In reality the multiple itself would also move with profitability, interest rates, competition and confidence. The company’s economics—not one eye-catching sales target—will ultimately decide the outcome.
7. Who controls Anthropic after the IPO?
The float may be substantial in dollars but smaller as a fraction of the company. The prospectus indicates that investors buying in the public offering would own approximately 6.3% of the Class A and Class N shares after the base IPO and placement, accounting for the secondary shares. A tight initial public ownership percentage can amplify trading volatility and index-related demand, but it also means a small early trading float is not evidence of permanent scarcity.
There is a more important governance feature. Anthropic is a Delaware public benefit corporation. Immediately before the IPO, a founder-controlled entity is planned to hold a Class F share with 50.1% of the aggregate voting power on general shareholder matters, without corresponding economic rights. The Long-Term Benefit Trust also has board-related powers through Class T governance arrangements.
Public investors can buy an economic claim, but they cannot assume their votes will determine the company’s direction in the way they might at a conventional one-share-one-vote company. Governance arrangements may protect Anthropic’s stated mission, but they reduce public shareholders’ ability to change management and capital allocation if financial performance disappoints. Source: SEC prospectus, governance and capital-stock sections.
8. What could make the IPO investment work—or fail?
The strongest case is that Claude becomes embedded in enterprises as an important working system rather than an occasional chatbot. Higher utilisation, greater customer retention and more efficient inference could convert today’s rapid sales growth into recurring cash profits. Broad distribution through Amazon and Google can accelerate adoption.
The difficult case is that Anthropic must continue to invest in an expensive technology race while the price of AI intelligence keeps falling. Google, OpenAI and other rivals can lower costs, bundle products, or catch up in model capabilities. Anthropic relies on major technology companies that can simultaneously act as investors, customers, suppliers, distributors and competitors. That creates both leverage and concentrated commercial risk.
A prudent reader should track five numbers after the listing:
- Realised quarterly revenue growth, not just an annualised run-rate metric.
- Compute cost divided by revenue, including the effect of short-term premium capacity.
- GAAP operating margins and actual operating cash flow, alongside share-based compensation and cash capital requirements.
- Commitments falling due in the next 12–24 months, including any additional partner financing or refinancing.
- Fully diluted shares, stock awards and whether growing market value is shared with new investors or diluted by future issuance.
Price discovery is another variable. The $70–$78 range remains indicative as of 16 November 2026. Reuters reported the roadshow was expected to run through Wednesday 18 November, with pricing expected then; an expected timetable is not a confirmed final price or executed trade. There was no publicly traded Anthropic stock on the date of this analysis. The planned ticker ANT should not be confused with a live market quote. Sources: official roadshow announcement; Reuters, 13 November.
The Compound assessment
Anthropic is already a very large revenue business. Its IPO investors are being asked to pay for an even larger future one.
The standout facts are Q3’s $17 billion in revenue, a major improvement in the operating economics from early 2025, and a substantial existing cash position. The uncomfortable facts are $900.9 billion of multi-year compute and lease commitments, an operating margin that turned negative again in Q3 and a valuation that can only be justified if growth remains extraordinary for years.
The question is not whether Anthropic has value. Its paying customers, rapid adoption and technical capacity establish that it does. The question is whether a price implying approximately a trillion dollars—or more on a broader share-count basis—leaves enough upside after allowing for lower-than-expected future revenue, dilution and huge operating requirements.
A terrific company can still be an unattractive investment if the IPO already prices in an extraordinary outcome. Conversely, a large reported accounting loss does not prove that the equity is worthless. For the next stage of the story, we would prioritise the final priced prospectus, the exact diluted share count, Q4 reported revenue and the disclosed cost of committed compute over speculative first-day share-price predictions.
Continue with the Anthropic private-company research profile, our earlier accounting-loss explainer, or the Compound company research directory for comparisons with listed infrastructure providers. The financial analysis above is not a personalised recommendation to subscribe for shares.
Research checked 16 November 2026, Europe/Dublin. US-dollar amounts, period definitions, source dates and proposed share terms are preserved. SEC figures include unaudited 2026 interim data. Market-sensitive terms can change before pricing. Forecast tables are explicitly illustrative and are not statements of Anthropic management guidance.
Cover: authentic Claude symbol and wordmark by Anthropic, with artwork sourced from Lobe Icons and independently documented on Wikimedia Commons (PD-textlogo; trademark rights remain with Anthropic). Artwork colours and proportions are unchanged; the neutral background is editorial layout. Compound.ie is not affiliated with or endorsed by Anthropic.


